Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of colchicine on renal fibrosis marker in patients with chronic kidney disease
TCTR20220214005Phase 2Enrolling by invitation
- Sponsor
- N/A
- Start
- Sep 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in chronic kidney disease (CKD), sponsored by N/A. Started Sep 2021; status: enrolling by invitation.
02
Drugs
colchicine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20220214005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220214005.